Beyond the Pivot: How a Lordotic Core is Rewriting Cervical Spine Surgery

LOUISVILLE, Colo. – September 24, 2026 – For decades, the gold standard for treating intractable cervical radiculopathy has been anterior cervical discectomy and fusion, a procedure that effectively relieves nerve compression by locking the affected vertebrae together. While reliable for pain relief, this approach fundamentally alters the biomechanics of the neck, transferring stress to adjacent segments and often necessitating future surgeries. The medical community has long sought a better way, pivoting toward motion-preserving artificial discs. Yet, preserving motion without restoring the spine's natural curvature has proven to be an incomplete solution.

Today, the publication of two-year clinical trial results in Spine Open provides compelling evidence that the next era of spine surgery has arrived. The peer-reviewed study, detailing the outcomes of the FDA-approved Synergy Disc, demonstrates that combining motion preservation with a targeted restoration of anatomical alignment yields clinical outcomes that significantly outpace traditional fusion. For patients, surgeons, and healthcare systems, these findings represent a critical juncture in how we define success in spinal intervention, proving that institutional innovation can dramatically elevate community wellbeing.

The prospective, multicenter Investigational Device Exemption (IDE) study evaluated 175 patients implanted with the device across 20 clinical sites in the United States. These outcomes were compared against 192 propensity-matched historical control patients who underwent traditional fusion. The results were stark: the investigational device achieved an 87.1 percent composite clinical success rate at 24 months, thoroughly eclipsing the 56.6 percent success rate of the fusion control group. This composite endpoint was not a simple metric; it required patients to meet five rigorous criteria, including meaningful functional improvement, neurological maintenance, and the total absence of secondary surgeries or device-related serious adverse events.

The Paradigm Shift: From Motion to Alignment

To understand the significance of this data, one must look at the evolution of cervical arthroplasty. Early-generation artificial discs functioned much like simple hinges or ball-and-socket joints. They successfully preserved movement but featured flat, non-lordotic endplates. When implanted, these devices could inadvertently flatten the natural curvature of the cervical spine, introducing localized segmental kyphosis. This unnatural flattening alters load distribution, accelerates facet joint wear, and ultimately shifts biomechanical strain to adjacent discs—the very problem artificial discs were designed to prevent.

The device at the center of the Spine Open publication takes a fundamentally different mechanical approach. It incorporates a pre-machined 6-degree lordotic core, specifically designed to match the natural, healthy curve of the subaxial cervical spine. By integrating this curvature directly into the mobile core, the implant does not merely allow the neck to move; it dictates that the neck moves in the correct anatomical posture.

The radiographic data from the trial validates this biomechanical hypothesis. Researchers found that the cervical disc angle in patients improved from a pathological 2.2 degrees preoperatively to a physiologic 7.5 degrees at 24 months.

"Publication of these results gives the spine community a comprehensive view of how the Synergy Disc performed across clinical outcomes, pain, function and alignment," said Neil Duggal, M.D., Chief Medical Officer of Synergy Spine Solutions and an author of the study. "Cervical disc replacement should do more than maintain movement after surgery. The goal is to preserve motion while restoring the mechanics and alignment of the cervical spine. These findings demonstrate the potential patient benefits of designing a disc around both."

Fusing vs. Moving: The Quality of Life Equation

Behind the complex statistical matching and radiographic measurements lies a deeply human narrative. For patients suffering from radiating arm pain, numbness, and debilitating neck stiffness, surgical intervention is a desperate bid to reclaim their quality of life. The data reveals that the type of intervention profoundly impacts the trajectory of that recovery.

According to the trial results, patients treated with the lordotic disc replacement reported roughly half the neck and arm pain of those who underwent fusion. On a 100-point visual analog scale, mean neck pain scores dropped to 15.6 for the arthroplasty group, compared to 30.2 for the fusion group. Worst arm pain scores mirrored this dramatic difference, sitting at 15.0 versus 32.2. Furthermore, 91.7 percent of the arthroplasty patients achieved clinically meaningful improvement in their Neck Disability Index scores, outpacing the 75.2 percent seen in the fusion cohort. Overall patient satisfaction reached an impressive 84.5 percent, compared to just 61.6 percent for fusion patients.

"When evaluating new technologies, surgeons want evidence that extends beyond the operating room and demonstrates meaningful patient benefit over time," said Luis M. Tumialán, MD, a board-certified neurosurgeon and investigator in the trial. "These results show patients experienced meaningful improvements in pain, function and satisfaction while maintaining motion, which is exactly the type of evidence that helps inform treatment decisions."

Beyond the mechanical advantages, the device's material composition addresses a critical, often-overlooked patient safety issue: metal hypersensitivity. Approximately 10 to 15 percent of the general population has some form of metal allergy, with nickel being the most prevalent culprit. Many legacy spinal implants utilize cobalt-chromium alloys that contain trace amounts of nickel, which can lead to localized inflammation, osteolysis, and intractable pain in sensitized individuals. By utilizing medical-grade, nickel-free titanium alloy endplates paired with an ultra-high molecular weight polyethylene core, the device eliminates this specific immunological risk while simultaneously reducing postoperative imaging artifacts.

Breaking the Fusion Monopoly

Despite the mounting clinical evidence favoring cervical disc replacement, traditional fusion still accounts for roughly 62 percent of all cervical spine interventions in the United States, while arthroplasty hovers below the 5 percent mark. Breaking this entrenched standard of care requires more than just good data; it requires strategic disruption within the commercial healthcare landscape.

The manufacturer's path to the U.S. market has been methodical. Leveraging more than a decade of clinical use across Europe and Australia, the company built a robust international registry before embarking on the rigorous U.S. IDE process. The device received Premarket Approval from the FDA in February 2026 for single-level use from C3 to C7, backed entirely by the superiority data now published in Spine Open.

The commercial challenge now shifts to institutional adoption. Hospital Value Analysis Committees and legacy vendor contracts heavily favor established orthopedic giants. Independent medical device companies must present undeniable clinical and economic value to displace these incumbents. The recent withdrawal of competing devices from the market due to wear-related complications has created a unique vacuum, providing an immediate opening for a differentiated, alignment-focused technology.

"This study's key strength is that the results connect the Synergy Disc's design with outcomes that matter to surgeons and patients," said Robyn Capobianco, Ph.D., Vice President of Clinical Affairs at Synergy Spine Solutions. "This publication adds to a growing body of evidence that cervical disc replacement technology can preserve motion, address alignment, and deliver better clinical outcomes than fusion. That combination is what sets the Synergy Disc apart."

As healthcare systems increasingly prioritize value-based care, the long-term economic benefits of reducing adjacent segment disease and secondary surgical interventions cannot be ignored. The two-year data provides a compelling foundation, but the true measure of institutional innovation will be how quickly surgical paradigms shift to embrace technologies that treat the entire biomechanical system rather than just the isolated symptom. The era of choosing between preserving motion and restoring alignment is effectively over; the standard has now been elevated to demand both, ensuring a healthier, more active future for patients everywhere.